Liav Abraham

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Liav Abraham works at CITI and is focused on the Healthcare sector with 269 price targets and ratings documented since 2012 spanning on 12 stocks. Analyst's average stock valuation to be materialised ratio is 62.11% with an average time for price targets to be met of 286.92 days.

Most recent stock forecast was given on ELAN, Elanco Animal Health Incorporated at 05-Aug-2021.

Liav Abraham best performing recommendations are on INSM (INSMED INCORPORATED).
The best stock recommendation documented was for TEVA (TEVA PHARMACEUTICAL INDUSTRIES LIMITED) at 11/13/2017. The price target of $13 was fulfilled within 4 days with a profit of $1.33 (11.4%) receiving and performance score of 28.49.

Average potential price target upside

Currently, out of the existing stock ratings of Liav Abraham - 14647 which are a Buy (73.85%), 4920 which are a Hold (24.81%), 266 which are a Sell (1.34%)

AGN ALKS ELAN ENDP HZNP SGYP TEVA ZTS JAZZ INSM MYL VTRS

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

193

$-0.02 (-0.01%)

178

2 years 11 months 8 days ago

4/11 (36.36%)

$28.2 (13.43%)

217

Buy

203

3 years 1 months 11 days ago

1/2 (50%)

$20.22 (11.61%)

95

Hold

203

$9.98 (5.17%)

178

3 years 1 months 19 days ago

7/21 (33.33%)

$41.11 (19.94%)

305

Hold

198

$4.98 (2.58%)

188

3 years 2 months 7 days ago

4/12 (33.33%)

$58.11 (36.01%)

222

Buy

190

3 years 7 months 22 days ago

1/9 (11.11%)

$50.42 (25.65%)

280

Show more analysts
AGN ALKS ELAN ENDP HZNP SGYP TEVA ZTS JAZZ INSM MYL VTRS